Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 17, 2024
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
[ Wed, Jul 17th 2024
] - WOPRAI
William Plovanic Maintained (ANGO) at Strong Buy with Decreased Target to $13 on, Jul 17th, 2024
William Plovanic of Canaccord Genuity, Maintained "AngioDynamics, Inc." (ANGO) at Strong Buy with Decreased Target from $18 to $13 on, Jul 17th, 2024.
William has made no other calls on ANGO in the last 4 months.
There is 1 other peer that has a rating on ANGO. Out of the 1 peers that are also analyzing ANGO, 0 agree with William's Rating of Hold.
This is the rating of the analyst that currently disagrees with William
- Steven Lichtman of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $12 on, Friday, April 5th, 2024
